26 August 2019 - On 3 October, the FDA and the Duke-Margolis Center for Health Policy will hold a conference, ...
21 August 2019 - A new report from the Bipartisan Policy Center makes recommendations to expand the use of real-world ...
9 August 2019 - The use of real-world evidence is evolving quickly. ...
15 July 2019 - As the FDA grapples with rising pressure to approve new medicines more quickly, a new analysis ...
11 July 2019 - The pharmaceutical market has undergone radical changes, including markedly increased prices for rare-disease drugs. ...
9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...
18 January 2019 - "We are in uncharted territory. This is a watershed moment in the life of this agency," he ...
23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...
10 January 2018 - According to US FDA regulations, the regulatory agency may refuse to file a new drug application ...
25 September 2017 - Since we launched our Patient Preference Initiative as part of our medical device regulatory decision-making process ...
7 September 2017 - We’re at a moment of extraordinary opportunity to improve the public health. New innovations are giving us ...
22 August 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
2 August 2017 - A core principle of good public health practice is to base all policy decisions on the highest-quality ...
13 July 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
22 March 2017 - Task force to establish roadmap and recommendations for use of big data in assessment of medicines ...